The on-demand webinar hosted by Greenlight Guru discusses the new regulatory requirements for post-market surveillance (PMS) under the European Union Medical Device Regulations (EU MDR), highlighting the importance of a proactive approach in monitoring medical devices to ensure their benefit-risk profile remains current, and explaining the impact of PMS on business and the product lifecycle.
Main points covered:
1. Understanding the new PMS requirements under MDR.
2. The business impact of these requirements.
3. How these requirements affect current product lifecycle/QMS.
4. The relationship between Post-Market Clinical Follow-up (PMCF) and PMS.
5. Key elements to include in PMS plans and reports.
Target Audience:
• Quality Managers
• Regulatory Affairs Professionals
• Medical Device Executives
• Product Development Professionals
Access the printable slides for this presentation here: www.greenlight.guru/webinar/p....
Негізгі бет Ғылым және технология Understanding Post-market Surveillance under EU MDR: Being Proactive, not Reactive
Пікірлер